RAD001 in Advanced Hepatocellular Carcinoma

NCT00516165 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: RAD001

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]